INSULIN ANTILIPOLYTIC (PREVENTS FAT LOSS)

  1. Antilipolytic effect of insulin in isolated fat cells of the rat
  2. The Antilipolytic action of insulin in obese subjects with resistance to its glucoregulatory action
  3. Effect of cell size on lipolysis and Antilipolytic action of insulin in human fat cells
  4. Antilipolytic action of insulin on fat cells
  5. Systemic resistance to the Antilipolytic effect of insulin in black and white women with visceral obesity
  6. Various phosphodiesterase subtypes mediate the in vivo Antilipolytic effect of insulin on adipose tissue and skeletal muscle in man
  7. Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the Antilipolytic action of insulin in isolated rat adipocytes
  8. Antilipolytic action of insulin: role of cAMP phosphodiesterase activation
  9. The Antilipolytic effect of insulin in human adipose tissue in obesity, diabetes mellitus, hyperinsulinemia, and starvation
  10. Adipose tissue lipolysis revisited (again!): lactate involvement in insulin Antilipolytic action
  11. Insensitivity of large rat adipocytes to the Antilipolytic effects of insulin
  12. Evidence for the key role of the adipocyte cGMP-inhibited cAMP phosphodiesterase in the Antilipolytic action of insulin
  13. Pro12Ala Polymorphism in the Peroxisome Proliferator–Activated Receptor-γ2 Gene Is Associated With Increased Antilipolytic insulin Sensitivity
  14. insulin receptor down-regulation and impaired Antilipolytic action of insulin in diabetic patients after pancreas/kidney transplantation
  15. Antilipolytic actions of vanadate and insulin in rat adipocytes mediated by distinctly different mechanisms
  16. A longitudinal study of the Antilipolytic effect of insulin in women following bariatric surgery
  17. Antilipolytic effects of insulin and adenylate cyclase inhibitors on isolated human fat cells.
  18. Effect of the Antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes …
  19. Regulation of insulin-stimulated glucose transport in the isolated rat adipocyte. cAMP-independent effects of lipolytic and Antilipolytic agents.
  20. Role of phosphodiesterase III in the Antilipolytic effect of insulin in vivo
  21. Influence of obesity on the Antilipolytic effect of insulin in isolated human fat cells obtained before and after glucose ingestion.
  22. insulin-mimetic compound hexaquis (benzylammonium) decavanadate is Antilipolytic in human fat cells
  23. Glucocorticoids antagonize tumor necrosis factor-α-stimulated lipolysis and resistance to the Antilipolytic effect of insulin in human adipocytes
  24. Evidence for marked sensitivity to the Antilipolytic action of insulin in obese maturity-onset diabetics
  25. The Antilipolytic effects of insulin and epidermal growth factor in rat adipocytes are mediated by different mechanisms
  26. Molecular mechanisms involved in the Antilipolytic action of insulin: phosphorylation and activation of a particulate adipocyte cAMP phosphodiesterase
  27. Antilipolytic actions of insulin on basal and hormone-induced lipolysis in rat adipocytes
  28. Overactivation of the endocannabinoid system alters the Antilipolytic action of insulin in mouse adipose tissue
  29. Comparative studies of the Antilipolytic effect of insulin and adenosine in the perifused isolated fat cell
  30. The Antilipolytic effect of insulin in human adipocytes requires activation of the phosphodiesterase
  31. Lowering of triglycerides by gemfibrozil affects neither the glucoregulatory nor Antilipolytic effect of insulin in type 2 (non-insulin-dependent) diabetic patients
  32. Glucose stimulation of the Antilipolytic effect of insulin in humans
  33. Resistance to the Antilipolytic effect of insulin in adipocytes of African-American compared to Caucasian postmenopausal women
  34. PKB inhibition prevents the stimulatory effect of insulin on glucose transport and protein translocation but not the Antilipolytic effect in rat adipocytes
  35. Upstream transcription factor 1 gene polymorphisms are associated with high Antilipolytic insulin sensitivity and show gene–gene interactions
  36. Mediation of the Antilipolytic and lipogenic effects of insulin in adipocytes by intracellular accumulation of hydrogen peroxide
  37. Studies on the sites of the Antilipolytic action of insulin in adipose tissue
  38. Islet-activating protein discriminates the Antilipolytic mechanism of insulin from that of other Antilipolytic compounds
  39. Genistein, a plant-derived isoflavone, counteracts the Antilipolytic action of insulin in isolated rat adipocytes
  40. insulin-like action of ouabain II. Primary Antilipolytic effect through inhibition of adenyl cyclase
  41. Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or Antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia
  42. The Antilipolytic effect of insulin does not require adenylate cyclase or phosphodiesterase action
  43. Cell size and the Antilipolytic effect of insulin in human subcutaneous adipose tissue
  44. Antilipolytic action of insulin in adipocytes from starved and diabetic rats during adenosine-controlled incubations
  45. The effect of an Antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patients
  46. Evidence for Separate Sites of Action for the Antilipolytic Effects of insulin and Prostaglandin E1
  47. Comparisons of the Effects of Bacillus subtilis Protease, Type VIII (Subtilopeptidase A), and insulin on Isolated Adipose Cells: II. Antilipolytic ACTION
  48. Preserved Antilipolytic insulin action is associated with a less atherogenic plasma lipid profile in healthy centenarians
  49. The Antilipolytic, insulin-like effect of growth hormone is caused by a net decrease of hormone-sensitive lipase phosphorylation
  50. A novel index of whole body Antilipolytic insulin action
  51. Effect of p-chlorophenoxyisobutyrate on the Antilipolytic action of insulin and insulin binding in isolated adipocytes
  52. Antilipolytic action of insulin in the perifused fat cell system
  53. PID1 alters the Antilipolytic action of insulin and increases lipolysis via inhibition of AKT/PKA pathway activation
  54. The glucoregulatory and Antilipolytic actions of insulin in abdominal obesity with normal or impaired glucose tolerance: an in vivo and in vitro study
  55. SUCROSE FEEDING IN MAN: Effects on Lipolysis and Antilipolytic Action of insulin in the Adipose Tissue
  56. Lipolysis and the Antilipolytic effect of insulin in adipocytes from rats adapted to a high-protein diet
  57. insulin-like, Antilipolytic actions of phospholipase A in isolated rat adipose cells
  58. Comparison of the responsiveness of perirenal adipose tissue of the rat, hamster, guinea pig and rabbit to the Antilipolytic action of insulin
  59. Mechanism of action of Antilipolytic agents: comparison of the effects of insulin, tolbutamide, and phenformin on lipolysis induced by dibutyryl cyclic AMP plus …
  60. A growth hormone (GH) analog that antagonizes the lipolytic effect but retains full insulin-like (Antilipolytic) activity of GH
  61. Antilipolytic effect of insulin and insulin receptor messenger RNA expression in adipocytes of infants, children, and adults
  62. Decreased insulin binding and Antilipolytic response in adipocytes from patients with Cushing’s syndrome
  63. The Antilipolytic Action of insulin on Adrenocorticotrophin‐Stimulated Rat Adipocytes: The Roles of Adenosine 3′, 5′‐Monophosphate and the Protein Kinase …
  64. Binding and Antilipolytic action of insulin in isolated adipocytes from cortisol-treated rats.
  65. Coupling of adenylate cyclase to lipolysis in permeabilized adipocytes: direct evidence that an Antilipolytic effect of insulin is independent of adenylate cyclase
  66. Influence of fasting and refeeding on the Antilipolytic effect of insulin in human fat cells obtained from obese subjects
  67. The Antilipolytic agent 3, 5-dimethylpyrazole inhibits insulin release in response to both nutrient secretagogues and cyclic adenosine monophosphate agonists in …
  68. Effects of different phosphodiesterase inhibitors on the Antilipolytic action of insulin in human adipocytes
  69. Effect of long-term nickel ingestion on insulin binding and Antilipolytic response in rat adipocytes
  70. Antilipolytic action of insulin in abdominal adipocytes of obese subjects before and during energy restriction. Influence of adenosine deaminase.
  71. Inhibition by cholera toxin of the Antilipolytic action of prostanoids, N6-(phenylisopropyl) adenosine and insulin
  72. Pertussis toxin reversal of the Antilipolytic action of insulin in rat adipocytes in the presence of forskolin does not involve cyclic AMP
  73. Wortmannin converts insulin but not oxytocin from an Antilipolytic to a lipolytic agent in the presence of forskolin
  74. Phorbol 12-myristate 13-acetate inhibits the Antilipolytic action of insulin, probably via the activity of protein kinase Cε
  75. A comparison of the Antilipolytic effects of nicotinic acid, methylisoxazole carboxylic acid, methylpyrazole carboxylic acid and insulin in isolated fat cells
  76. Antilipolytic Effect of insulin in Non‐insulin‐dependent Diabetes Mellitus after Conventional Treatment with Diet and Sulfonylurea
  77. The Pro12Ala polymorphism in the peroxisome proliferator activated receptor [gamma] 2 gene is associated with increased Antilipolytic insulin sensitivity in lean …
  78. Evaluation of the effects of forskolin and the Antilipolytic agents insulin and nicotinic acid on cyclic AMP levels in rat epididymal adipocytes.
  79. insulin-Like, Antilipolytic Effect of 12-O-Tetradecanoyl Phorbol 13-Acetate in Rat White Adipocytes
  80. Effect of experimentally-induced chronic hyperprolactinemia on insulin binding and Antilipolytic response in adipocytes from male rats.
  81. Effect of SC-19220, a prostaglandin inhibitor on the Antilipolytic action of prostaglandin E2, propranalol and insulin in the isolated rat adipocyte
  82. 1222-P: Adipose Tissue Antilipolytic insulin Sensitivity Protects against Whole-Body insulin Resistance and Lowers Acylcarnitine Accumulation in Adults with Obesity
  83. Investigations on the Antilipolytic Activity of Sulfonylureas in Man with Indications on Limit Dosages Concerning their insulin-Secreting Properties
  84. Variability in Sensitivity to the Antilipolytic Effect of insulin in Adipocytes from Obese Nondiabetic Premenopausal Women
  85. The Antilipolytic effect of insulin and epidermal growth factor in rat adipocytes are mediated by different mechanisms
  86. Temperature and benzyl alcohol as probes of the Antilipolytic mechanism of insulin action in adipocytes
  87. Decreased Antilipolytic effect of insulin is associated with low glucose oxidation rate and dyslipidemias in familial combined hyperlipidemia
  88. 230-OR: Exercise Training Improved Antilipolytic Sensitivity to insulin in Obese Adults with Low Sensitivity to insulin before Training
  89. PID1 alters Antilipolytic action of insulin and increases lipolysis via Inhibited the activation of AKT/PKA Pathway
  90. … , and carboxyglycylamide with reference to their blood-sugar-decreasing and Antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin
  91. Correction: PID1 alters the Antilipolytic action of insulin and increases lipolysis via inhibition of AKT/PKA pathway activation
  92. Activation of adipose tissue cannabinoid receptors 1 (CB1R) alters Antilipolytic action of insulin and increases lipolysis in mice
  93. … blood sugar decreasing and Antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin
Shopping Cart
Scroll to Top